Gastrointestinal cancers: changing paradigms in immuno-oncology
This 1-day program is intended to create an opportunity for HCPs to participate in a scientific exchange of ideas on issues significant to gastrointestinal cancers, in particular colorectal and gastroesophageal cancers.
Key scientific leaders serving on the faculty panel will discuss a wide range of topics relating to gastrointestinal cancers.
How to participate the meeting
To encourage participation, this event will take place in a hybrid form. It will be possible to follow the activity at the congress venue or remotely.The two buttons below allow you to register according to the desired method, as long as available places are available. Enrollment in the course can only be done through the online procedure, no new registrations will be accepted at the congress venue.
Go to the Residential Course - NaplesDue to organisational reasons, participation in the activity must be online - as selected during the enrollment phase - for its entire duration. It is possible to change the mode of participation (in-class vs online) no later than 10 days prior to the start date of the activity. If an activity requires the payment of a fee, our administrative office will provide instructions about the possible refund or balance owing.Participants who will follow the activity remotely will need a stable and fast internet connection and a device (PC, Smartphone, Tablet) with a recent internet browser (i.e. any updated version of Chrome or Firefox).
Registration of participants and welcome coffee
Chairs: Fortunato Ciardiello, Stefano Cascinu 11.00
Fortunato Ciardiello, Stefano Cascinu 11.15
The changing paradigm in immuno-oncology: the past vs future in the treatment of gastrointestinal cancers
Scott Kopetz 11.45
Changing dynamics in treatment of MSI-H cancers
Fortunato Ciardiello 12.15
Changing dynamics in treatment of Upper GI cancers
Stefano Cascinu 12.45
Fortunato Ciardiello, Stefano Cascinu 13.10
Federica Morano, Chairs: Sara Lonardi, Federica Morano 14.10
Treatment in early stages of Upper GI cancer: where are we?
Ferdinando De Vita 14.30
The role of biomarkers in GI cancers treatment
Renato Franco 15.00
Immunotherapy in GI cancers: open questions
Scott Kopetz 15.30
Integrating IO into clinical practice: management of toxicities
Sara Lonardi 16.00
Integrating IO into clinical practice: nutritional and supportive care
Stefano Cascinu 16.30
Interactive clinical cases
Sara Lonardi, Federica Morano 17.45
Fortunato Ciardiello, Stefano Cascinu 18.00